The salubrious effects of ascorbic acid on cyclophosphamide instigated lipid abnormalities in fibrosarcoma bearing rats

Harikrishnan Vasavi, Muthusamy Thangaraju, Jeganathan Ramesh Babu, Panchanatham Sachdanandam

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The combined effect of cyclophosphamide and ascorbic acid on plasma lipids and lipoprotein profiles are important since, ascorbic acid encumbered the lipid abnormalities initiated by cyclophosphamide during cancer chemotherapy. Hence, the study was launched to appraise the salutary role of ascorbic acid in cyclophosphamide administered fibrosarcoma bearing rats. Fibrosarcoma cell line induced rats were treated with cyclophosphamide (10 mg/kg body weight) and ascorbic acid (200 mg/kg body weight) individually and in combination for 28 days. The concentration of plasma lipids and lipoprotein profiles were determined in control and experimental animals. The untreated, as well as cyclophosphamide administered fibrosarcoma bearing rats, divulged significantly increased levels of plasma total cholesterol, triglycerides, phospholipids, VLDL- and LDL-cholesterol, as compared with their respective control animals. In contrast, ester and HDL-cholesterol levels exhibited a marked decrease in these animals. Similar observations were also noticed in liver lipid values, as well. However, these lipid abnormalities were corrected by the co-administration of ascorbic acid. These results suggested, that some clinical entanglement of cyclophosphamide was refrained by co-administration of ascorbic acid in tumor stress condition.

Original languageEnglish (US)
Pages (from-to)71-83
Number of pages13
JournalCancer Biochemistry Biophysics
Volume16
Issue number1
StatePublished - Dec 1 1997
Externally publishedYes

Fingerprint

Fibrosarcoma
Cyclophosphamide
Ascorbic Acid
Lipids
Lipoproteins
Body Weight
VLDL Cholesterol
LDL Cholesterol
Neoplasms
Phospholipids
Cholesterol
Drug Therapy
Cell Line
Liver

Keywords

  • Cyclophosphamide, ascorbic acid
  • Fibrosarcoma
  • Hyperlipidemia

ASJC Scopus subject areas

  • Biophysics
  • Cancer Research

Cite this

The salubrious effects of ascorbic acid on cyclophosphamide instigated lipid abnormalities in fibrosarcoma bearing rats. / Vasavi, Harikrishnan; Thangaraju, Muthusamy; Babu, Jeganathan Ramesh; Sachdanandam, Panchanatham.

In: Cancer Biochemistry Biophysics, Vol. 16, No. 1, 01.12.1997, p. 71-83.

Research output: Contribution to journalArticle

Vasavi, Harikrishnan ; Thangaraju, Muthusamy ; Babu, Jeganathan Ramesh ; Sachdanandam, Panchanatham. / The salubrious effects of ascorbic acid on cyclophosphamide instigated lipid abnormalities in fibrosarcoma bearing rats. In: Cancer Biochemistry Biophysics. 1997 ; Vol. 16, No. 1. pp. 71-83.
@article{3ea0ba382d034958acaf959d309eb5ff,
title = "The salubrious effects of ascorbic acid on cyclophosphamide instigated lipid abnormalities in fibrosarcoma bearing rats",
abstract = "The combined effect of cyclophosphamide and ascorbic acid on plasma lipids and lipoprotein profiles are important since, ascorbic acid encumbered the lipid abnormalities initiated by cyclophosphamide during cancer chemotherapy. Hence, the study was launched to appraise the salutary role of ascorbic acid in cyclophosphamide administered fibrosarcoma bearing rats. Fibrosarcoma cell line induced rats were treated with cyclophosphamide (10 mg/kg body weight) and ascorbic acid (200 mg/kg body weight) individually and in combination for 28 days. The concentration of plasma lipids and lipoprotein profiles were determined in control and experimental animals. The untreated, as well as cyclophosphamide administered fibrosarcoma bearing rats, divulged significantly increased levels of plasma total cholesterol, triglycerides, phospholipids, VLDL- and LDL-cholesterol, as compared with their respective control animals. In contrast, ester and HDL-cholesterol levels exhibited a marked decrease in these animals. Similar observations were also noticed in liver lipid values, as well. However, these lipid abnormalities were corrected by the co-administration of ascorbic acid. These results suggested, that some clinical entanglement of cyclophosphamide was refrained by co-administration of ascorbic acid in tumor stress condition.",
keywords = "Cyclophosphamide, ascorbic acid, Fibrosarcoma, Hyperlipidemia",
author = "Harikrishnan Vasavi and Muthusamy Thangaraju and Babu, {Jeganathan Ramesh} and Panchanatham Sachdanandam",
year = "1997",
month = "12",
day = "1",
language = "English (US)",
volume = "16",
pages = "71--83",
journal = "Cancer Biochemistry Biophysics",
issn = "0305-7232",
publisher = "American Cancer Society, Inc.",
number = "1",

}

TY - JOUR

T1 - The salubrious effects of ascorbic acid on cyclophosphamide instigated lipid abnormalities in fibrosarcoma bearing rats

AU - Vasavi, Harikrishnan

AU - Thangaraju, Muthusamy

AU - Babu, Jeganathan Ramesh

AU - Sachdanandam, Panchanatham

PY - 1997/12/1

Y1 - 1997/12/1

N2 - The combined effect of cyclophosphamide and ascorbic acid on plasma lipids and lipoprotein profiles are important since, ascorbic acid encumbered the lipid abnormalities initiated by cyclophosphamide during cancer chemotherapy. Hence, the study was launched to appraise the salutary role of ascorbic acid in cyclophosphamide administered fibrosarcoma bearing rats. Fibrosarcoma cell line induced rats were treated with cyclophosphamide (10 mg/kg body weight) and ascorbic acid (200 mg/kg body weight) individually and in combination for 28 days. The concentration of plasma lipids and lipoprotein profiles were determined in control and experimental animals. The untreated, as well as cyclophosphamide administered fibrosarcoma bearing rats, divulged significantly increased levels of plasma total cholesterol, triglycerides, phospholipids, VLDL- and LDL-cholesterol, as compared with their respective control animals. In contrast, ester and HDL-cholesterol levels exhibited a marked decrease in these animals. Similar observations were also noticed in liver lipid values, as well. However, these lipid abnormalities were corrected by the co-administration of ascorbic acid. These results suggested, that some clinical entanglement of cyclophosphamide was refrained by co-administration of ascorbic acid in tumor stress condition.

AB - The combined effect of cyclophosphamide and ascorbic acid on plasma lipids and lipoprotein profiles are important since, ascorbic acid encumbered the lipid abnormalities initiated by cyclophosphamide during cancer chemotherapy. Hence, the study was launched to appraise the salutary role of ascorbic acid in cyclophosphamide administered fibrosarcoma bearing rats. Fibrosarcoma cell line induced rats were treated with cyclophosphamide (10 mg/kg body weight) and ascorbic acid (200 mg/kg body weight) individually and in combination for 28 days. The concentration of plasma lipids and lipoprotein profiles were determined in control and experimental animals. The untreated, as well as cyclophosphamide administered fibrosarcoma bearing rats, divulged significantly increased levels of plasma total cholesterol, triglycerides, phospholipids, VLDL- and LDL-cholesterol, as compared with their respective control animals. In contrast, ester and HDL-cholesterol levels exhibited a marked decrease in these animals. Similar observations were also noticed in liver lipid values, as well. However, these lipid abnormalities were corrected by the co-administration of ascorbic acid. These results suggested, that some clinical entanglement of cyclophosphamide was refrained by co-administration of ascorbic acid in tumor stress condition.

KW - Cyclophosphamide, ascorbic acid

KW - Fibrosarcoma

KW - Hyperlipidemia

UR - http://www.scopus.com/inward/record.url?scp=0032082769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032082769&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 71

EP - 83

JO - Cancer Biochemistry Biophysics

JF - Cancer Biochemistry Biophysics

SN - 0305-7232

IS - 1

ER -